- Health
-
Pandemics & Infectious Diseases
Medical Treatment & Drug Development
Bacteria & Other Microorganisms
Antimicrobials, Antibiotics & Drug Resistances
Vaccines
Post-Doctoral Fellowships
United Kingdom
Identification of bacterial factors involved in virulence and shared by main serogroups of Pseudomonas aeruginosa
Hospital-acquired infections are the fourth leading cause of patient death. Doctor Roux is tackling the most prevalent of these nosocomial infections – pneumonia – caused by the bacteria Pseudomonas aeruginosa. He began by successfully identifying the proteins responsible for the passage of bacteria from the environment into the guts of immunosuppressed mice. These are perfect targets for hospital-acquired infections, mimicking hospitalized patients weakened by anti-cancer or anti-burn treatments. Dr. Roux has also singled out the genetic mechanisms for the bacteria’s acquired resistance to antibiotics. He is now investigating Pseudomonas infection in the lungs. Indeed, in hospitals, these bacteria are most often found in ventilator-associated pneumonia. The in-depth and thorough understanding of Pseudomonas aeruginosa infection provided by Dr. Roux’s research could soon result in a vaccine against pneumonia and the other diseases caused by these bacteria.
Prevent pneumonia in hospitalized patients
To add or modify information on this page, please contact us at the following address: [email protected]
Damien
ROUX
Institution
The Brigham and Women's Hospital
Country
United Kingdom
Nationality
French
Related publications
Health
Health Technologies
Medical Treatment & Drug Development
Biotech- and Nanotechnology
Drug Delivery
France
Abolishing frontiers between fundamental science and medicine : building on the potential of biomedical ultrasound
Read more
Mickaël
TANTER